1. Sphingolipids at the Crossroads of NAFLD and Senescence
   Mariana Nikolova-Karakashian, 2018, Sphingolipids in Cancer CrossRef
2. An intrinsic lipid-binding interface controls sphingosine kinase 1 function
   Michael J. Pulkoski-Gross et al, 2018, Journal of Lipid Research CrossRef
3. Phospho-Sphingosine Kinase 1 Expression in Lymphatic Spread of Esophageal Squamous Cell Carcinoma
   Mariko Nemoto et al, 2019, Journal of Surgical Research CrossRef
4. SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mTOR Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma
   Liqiao Chen et al, 2024, The Tohoku Journal of Experimental Medicine CrossRef
5. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis
   Chuanmeng Zhang et al, 2022, Disease Markers CrossRef
6. Sphingolipid Metabolism in Cancer: Potential Therapeutic Target
   Mohamad Bahij Moumneh et al, 2023, Handbook of Cancer and Immunology CrossRef
7. Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease
   Burkhard Kleuser, 2018, International Journal of Molecular Sciences CrossRef
8. “Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer
   Nahal Haddadi et al, 2017, International Journal of Molecular Sciences CrossRef
9. Is Sphingosine-1-Phosphate a Regulator of Tumor Vascular Functionality?
   Manale Karam et al, 2022, Cancers CrossRef
10. Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
    Vicki Xie et al, 2018, Biomarker Research CrossRef
11. Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
    Xin Tracy Liu et al, 2024, Journal of Translational Medicine CrossRef
12. The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
    Run-Ze Li et al, 2022, Frontiers in Oncology CrossRef
13. Cytotoxic Effects of Resveratrol and Its Combinations with Ceramide Metabolism Inhibitors on FLT3 Positive Acute Myeloid Leukemia
    Nur Şebnem ERSÖZ et al, 2020, Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi CrossRef
14. The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma
    Hong Yu et al, 2022, Emergency Medicine International CrossRef
15. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment
    Chunyang Jiang et al, 2020, Clinical Genetics CrossRef
16. AUF-1 knockdown in mice undermines gut microbial butyrate-driven hypocholesterolemia through AUF-1–Dicer-1–mir-122 hierarchy
    Oishika Das et al, 2022, Frontiers in Cellular and Infection Microbiology CrossRef
17. The altered lipidome of hepatocellular carcinoma
    Shawn Lu Wen Tan et al, 2022, Seminars in Cancer Biology CrossRef
18. Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice
    Jinbiao Chen et al, 2018, Oncotarget CrossRef
19. Residual risk of liver disease after hepatitis C virus eradication
    Francesco Negro, 2021, Journal of Hepatology CrossRef
20. Resveratrol (3, 5, 4′-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain
    K. Alexa Orr Gandy et al, 2019, Journal of Neuroimmune Pharmacology CrossRef
21. Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine‐1‐phosphate and ceramide in human hepatocellular carcinoma
    Kohei Miura et al, 2021, Hepatology Research CrossRef
22. Sphingolipid Pathway Enzymes Modulate Cell Fate and Immune Responses
    S Molino et al, 2017, Immunotherapy CrossRef
23. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma
    Michael Maceyka et al, 2019, Lipid Signaling in Human Diseases CrossRef
24. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
    Nourdine Hamdane et al, 2019, Gastroenterology CrossRef
25. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
    Loraine Kay D. Cabral et al, 2022, Cancers CrossRef
26. Antineoplastic Agents Targeting Sphingolipid Pathways
    Alexander Kroll et al, 2020, Frontiers in Oncology CrossRef